ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 219 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 0.44 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,000 | – | 2 | – | 0.00% | – |
| Q2 2021 | $0 | -100.0% | 0 | -100.0% | 0.00% | – |
| Q1 2021 | $1,000 | 0.0% | 13 | +8.3% | 0.00% | – |
| Q4 2020 | $1,000 | – | 12 | +9.1% | 0.00% | – |
| Q3 2020 | $0 | – | 11 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | – | 0 | – | 0.00% | – |
| Q4 2019 | $0 | – | 0 | – | 0.00% | – |
| Q3 2019 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q1 2019 | $22,000 | +83.3% | 500 | +63.9% | 0.00% | +200.0% |
| Q4 2018 | $12,000 | – | 305 | +6000.0% | 0.00% | – |
| Q3 2018 | $0 | -100.0% | 5 | -85.7% | 0.00% | – |
| Q2 2018 | $2,000 | +100.0% | 35 | 0.0% | 0.00% | – |
| Q1 2018 | $1,000 | 0.0% | 35 | 0.0% | 0.00% | – |
| Q4 2017 | $1,000 | -75.0% | 35 | -75.0% | 0.00% | – |
| Q3 2017 | $4,000 | +100.0% | 140 | 0.0% | 0.00% | – |
| Q2 2017 | $2,000 | -90.9% | 140 | -72.0% | 0.00% | -100.0% |
| Q1 2016 | $22,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 139,528 | $6,083,000 | 4.46% |
| Eversept Partners, LP | 134,151 | $5,848,984 | 2.68% |
| DAFNA Capital Management LLC | 95,242 | $4,153,000 | 1.94% |
| GREAT POINT PARTNERS LLC | 302,000 | $13,167,000 | 1.82% |
| Atika Capital Management LLC | 190,000 | $8,284,000 | 1.59% |
| Crawford Lake Capital Management, LLC | 205,600 | $8,964,000 | 1.57% |
| Crawford Lake Capital Management, LLC | 205,688 | $8,968,000 | 1.57% |
| Cormorant Asset Management, LP | 450,000 | $19,620,000 | 1.45% |
| SENZAR ASSET MANAGEMENT, LLC | 11,123 | $485,000 | 1.40% |
| Rhenman & Partners Asset Management AB | 284,621 | $12,409,000 | 1.27% |